Drugs / MVA strain monkeypox attenuated live vaccine
MVA strain monkeypox attenuated live vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06771479 | Jan 2025 → Jan 2026 overdue | monkeypox | Shanghai Institute Of Biological Products | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MVA strain monkeypox attenuated live vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06771479 ↗ |
| Modality | Vaccine | “The experimental vaccine MVA strain monkeypox attenuated live vaccine has two different doses (low dose and high dose).” NCT06771479 ↗ |